A Transient Efect of Convalescent Plasma Therapy in a Patient with Severe Covonavirus Disease 2019: A Case Report

2Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A 65-year-old male patient with an end-stage renal disease was diagnosed with coronavirus disease 2019 (COVID-19) by reverse transcription polymerase chain reaction. The patient complained of cough, sputum, and respiratory distress that worsened three days ago. The patient required mechanical ventilation and extracorporeal mentrane oxygenation. On day 9, convalescent plasma collected from a 34-year old man who recovered from COVID-19 45 days ago was administered. The patient showed immediate clinical improvement. However, on day 14, the patient's clinical course worsened again. On day 19 and day 24, vancomycin-resistant Enterococcus faecium bacteremia and methicillin-resistant Staphylococcus aureus pneumonia were found. Afer long-term supportive care, he slowly recovered. He was discharged on day 91 without any oxygen requirement. This case report suggests that convalescent plasma therapy might just provide a short-term relief and that persistent efort for critical care is necessary to save patients from severe COVID-19.

Cite

CITATION STYLE

APA

Baek, A. R., Choo, E. J., Kim, J. Y., Ha, T. S., Park, S. W., Shin, H. B., … Kim, T. (2022). A Transient Efect of Convalescent Plasma Therapy in a Patient with Severe Covonavirus Disease 2019: A Case Report. Infection and Chemotherapy, 54(2). https://doi.org/10.3947/IC.2020.0089

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free